Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

 

 

Bacillus coagulans, earlier known as lactobacillus sporogenes and generally termed as Lactic Acid Bacteria (LAB), is a gram positive, spore-forming bacterium utilized as a probiotic. Bacillus coagulans is non-pathogenic, beneficial and safe for human consumption. It is used in various therapeutic treatments such as digestive problems, diarrhea, constipation, lactose intolerance, bacterial vaginosis, cholesterol reduction and immunity enhancement. Bacillus coagulans is compatible with vitamins, enzymes, electrolytes, proteins and carbohydrates, which makes it a cost-effective probiotic that can be incorporated into a wide range of foods. Bacillus coagulans is GRAS affirmed and being a tough and stable probiotic that can withstand a harsh acidic environment, it is a popular probiotic choice in food and pharmaceutical industries.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8434

Bacillus Coagulans – A Safe, Natural and Effective Way to Balance Intestinal System and Maintain Strong Immune and Digestive System

The bacillus coagulans market is driven by applications in functional foods and beverages such as breakfast cereals, sports beverages, protein bars and shakes and bakery products. Bacillus coagulans is a suitable choice for bakery products as it can withstand high temperatures required during baking. Besides usage in the food and beverages industry, bacillus coagulans also finds application in the supplements sector as a probiotic. With rising health concerns among the global population, probiotics have been witnessing high demand, which in turn has been driving the demand for bacillus coagulans. The use of probiotics containing bacillus coagulans is a safe, natural and effective way to balance the intestinal system and maintain a strong immune and digestive system.

The lack of awareness among consumers regarding the effectiveness of bacillus coagulans restricts the growth of the market to an extent. The increasing demand for bacillus coagulans products in emerging economies is expected to provide growth opportunities for market participants.

Global Bacillus Coagulans Market: Market Participants

Sabinsa Corp., Mitsubishi, Syngen Biotech Co., Unique Biotech, Aumgene Bioscience, Microbax, JBH Biotech, sanzyme are some of the key players identified in the global Bacillus coagulans market.

Global Bacillus Coagulans Market: Key Developments

Increasing investments on R&D activities to launch innovative products in functional foods are propelling the bacillus coagulans market growth. Across the globe, strains expressing unique and particular characteristics are of great interest. Although a reasonable number of commercial probiotic strains are available, novel strains with better potency are being continuously searched, which may enable health benefits with the specific targeted functional properties. Manufacturers are focusing on developing innovative and effective solutions through fermentation technology to improve the overall yield and quality of the product.

On 14th September, 2017, Sabinsa Corp. was successfully granted a U.S. patent for its shelf stable probiotic LactoSpore® Bacillus coagulans product combined with cranberry seed fibers. With the aid of natural fiber from cranberry, the viable colony count of the bacillus coagulans was found to increase. Studies have shown that lactospore® is found to reverse depression symptoms in patients suffering from IBS as well as improve cholesterol levels.

Global Bacillus Coagulans Market: Opportunities for Market Participants

Asia Pacific holds a substantial revenue share in the global bacillus coagulans market with ASEAN, India, and China pegged to be prominent markets for bacillus coagulans. North America is pegged to be next in line after Asia Pacific. Asia Pacific is also projected to be a fast growing market, owing to the rising healthcare spending in the region.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-8434

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Bacillus Coagulans Market: Segmentation

Segmentation of the bacillus coagulans market on the basis of the type:

  • Bacillus coagulans type 1
  • Bacillus coagulans type 2
  • Bacillus coagulans type 3

Segmentation of the bacillus coagulans market on the basis of the end use:

  • Food and beverage
  • Bakery products
  • Dairy products
  • Processed foods
  • Pharmaceuticals
  • Dietary supplements
  • Animal feed
  • Other

Segmentation of the bacillus coagulans market on the basis of the distribution channel:

  • Wholesale
  • Online retailer
  • Supermarket
  • Specialty stores

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/8434

Report Highlights:

Related Reports :

Microencapsulation MarketThe global Microencapsulation market is estimated to be valued at USD 6.5 billion in 2022 and is projected to reach USD 10.3 billion by 2032, at a CAGR of 8.2% from 2022 to 2032.

Food Amino Acids MarketThe food amino acids market was estimated at USD 4.9 billion in 2017 and is projected to grow at a CAGR of 8.1 % from 2018, to reach a value of USD 6.6 billion by 2022. The global food amino acids market is estimated to be USD 11.6 billion in 2032

Contact Us:                                                      

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

 

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts